These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction. Chao R; Clowers DE Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578 [TBL] [Abstract][Full Text] [Related]
24. Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. Shamloul R; Atteya A; Elnashaar A; Gadallah A; Zohdy W; Abdelsalam W J Sex Med; 2005 Jan; 2(1):117-20. PubMed ID: 16422914 [TBL] [Abstract][Full Text] [Related]
25. Intracavernous self-injection for erectile failure. Ruutu M; Lindström BL; Virtanen J; Alfthan O Eur Urol; 1988; 15(1-2):96-8. PubMed ID: 3215245 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological erection: diagnosis and treatment applications in 69 patients. Nellans RE; Ellis LR; Kramer-Levien D J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712 [TBL] [Abstract][Full Text] [Related]
31. Intracavernous injections of papaverine and phentolamine: correlation with penile brachial index. Lakin MM; Montague DK Urology; 1989 May; 33(5):383-6. PubMed ID: 2775361 [TBL] [Abstract][Full Text] [Related]
32. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction]. Steffens J; Postma HJ; Steffens L Urologe A; 1988 Jan; 27(1):14-6. PubMed ID: 3363768 [TBL] [Abstract][Full Text] [Related]
33. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245 [TBL] [Abstract][Full Text] [Related]
34. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149 [TBL] [Abstract][Full Text] [Related]
35. Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined delivery. Stief CG; Wetterauer U J Urol; 1988 Dec; 140(6):1415-6. PubMed ID: 3193506 [TBL] [Abstract][Full Text] [Related]
36. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction. Purvis K; Egdetveit I; Christiansen E Int J Impot Res; 1999 Oct; 11(5):287-99. PubMed ID: 10553808 [TBL] [Abstract][Full Text] [Related]
37. Vasoactive intracavernous pharmacotherapy. Sidi AA Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756 [TBL] [Abstract][Full Text] [Related]
38. Intracavernous self-injection of papaverine and verapamil: a clinical experience. Bolayir K; Gökşin N Acta Chir Hung; 1994; 34(3-4):253-6. PubMed ID: 7618376 [TBL] [Abstract][Full Text] [Related]
39. Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation. Hadzija BW; Mattocks AM; Stahl GM J Urol; 1988 Jul; 140(1):64-5. PubMed ID: 2454330 [TBL] [Abstract][Full Text] [Related]
40. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. Zorgniotti AW; Lefleur RS J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]